Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston west Nile virus cohort

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Nolan, Melissa S ^a   Podoll, Amber S ^b   Hause, Anne M ^c   Akers, Katherine M ^b   Finkel, Kevin W ^b   Murray, Kristy O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; EVIDENCE BASED MEDICINE; FEMALE; FLAVIVIRUS INFECTION; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; WEST NILE FLAVIVIRUS;

ACUTE-PHASE PROTEINS; AGED; CHEMOKINE CCL2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LIPOCALINS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TEXAS; WEST NILE FEVER; WEST NILE VIRUS;

ANIMALIA; WEST NILE VIRUS;

EID: 84863673025     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040374     Document Type: Article

References (21)

1. Lindsey NP, Staples JE, Lehman JA, Fischer M, (2010) Surveillance for human West Nile virus disease-United States, 1999-2008. Morb Mort Weekly Report 59: 1-17.
2. Tesh RB, Siirin M, Guzman H, Travassos da Rosa APA, Wu X, et al. (2010) Persistent west nile virus infection in the gold hamster: Studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis. 192: 287-295.
3. Murray K, Walker C, Herrington E, Lewis JA, McCormick J, et al. (2010) Persistent infection with West Nile virus years after initial infection. J Infect Dis. 201(1): 2-4.
4. Tonry JH, Brown CB, Cropp CB, Co JK, Bennett SN, et al. (2005) West Nile virus detection in urine. Emerg Infect Dis. 11(8): 1294-1296.
5. Baty SA, Gibney KB, Staples JE, Patterson AB, Levy C, et al. (2012) Evaluation for West Nile Virus (WNV) RNA in Urine of Patients Within 5 Months of WNV Infection. J Infect Dis205(9): 1476-1477.
6. Murray KO, Baraniuk S, Resnick M, Arafat R, Kilborn C, et al. (2008) Clinical Investigation of Hospitalized West Nile Virus Cases in Houston, 2002-2004. Vector Borne Zoonotic Dis 8: 167-174.
7. Murray K, Baraniuk S, Resnick M, Arafat R, Kilborn C, et al. (2006) Risk factors for encephalitis and death from west nile virus infection. Epidemiol Infect. 12 134(6): 1325-1332.
8. Lindsey NP, Sejvar JJ, Bode AV, Pape WJ, Campbell GL, (2012) Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003. VectorBorne Zoonotic Dis12(3): 230-235.
9. directory of services. Quest Diagnostics Incorporated. (2010)
10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Inter Med 130(6): 461-470.
11. KDOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification [Internet].: Kidney Disease Outcomes Quality Initiative Available:http://www.kidney.org/professionals/KDOQI/guidelines_ckd/toc.htm.(2002)
12. Altemtam N, Russell J, El Nahas M, (2012) A study of the natural history of diabetic kidney disease (DKD). Nephrol Dial Transpl27(5): 1847-1854.
13. Murray KO, Nolan MS, Yan C Persistence of Immunoglobulin-M antibodies up to 8 years following infection with West Nile virus. Clin Vaccine Immunol Submitted.
14. Prince HE, Tobler LH, Lape-Nixon M, Foster GA, Stramer SL, et al. (2005) Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol. 43(9): 4316-4320.
15. Papa A, Danis K, Athanasiasdou A, Delianidou M, Panagiotopoulos T, (2011) Persistence of West Nile virus immunoglobulin M antibodies, Greece. J Med Virol. 83(10): 1857-1860.
16. Zhang X, Nagaraja HN, Nadasdy T, Song H, McKinley A, et al. (2012) A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int 81(4): 401-406.
17. Damman K, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL, (2008) Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail 10: 997-1000.
18. Devarajan P, (2010) Review: Neutrophil gelatinase-associated lipocalin: A troponin-like biomarker for human acute kidney injury. J Nephrol 15: 419-428.
19. Haase-Fielitz A, Bellomo R, Devarajan P, Bennett M, Story D, et al. (2009) The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury. Nephrol Dial Transpl24: 3349-3354.
20. Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, et al. (2009) A new equation to estimate glomerular filtration rate. Ann Inter Med 150(9): 604-612.
21. Clark WF, Macnab JJ, Sontrop JM, Jain AK, Moist L, et al. (2011) Dipstick proteinuria as a screening strategy to identify rapid renal decline. Clin JAm SoNephro. 22(9): 1729-1736.